ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "A04" (70)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Ondansetron (A04AA01) 38 products WHO-DDD DrugBank.ca 
L IPCI Zofran 4 mg/2 mL5 x 2 ml41.6161.0020 %Concentrate for infusion: Ondansetronum 4mg / 2mlSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Zofran 4 mg/2 mL10 x 2 ml83.22105.6020 %Concentrate for infusion: Ondansetronum 4mg / 2mlSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Zofran 8 mg/4 mL5 x 4 ml76.7398.7020 %Concentrate for infusion: Ondansetronum 8mg / 4mlSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Zofran 8 mg/4 mL8 x 4 ml122.77148.0520 %Concentrate for infusion: Ondansetronum 8mg / 4mlSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Zofran 4 mg10 Tablet(s)26.5945.0520 %Coated tablets: Ondansetronum 4 mgSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Zofran 8 mg6 Tablet(s)26.6845.1020 %Coated tablets: Ondansetronum 8 mgSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Zofran Zydis 4 mg - T10 Tablet(s)26.5945.0520 %Zydis Lingualtabletten: Ondansetronum 4 mgSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Zofran Zydis 8 mg ‐ I - T6 Tablet(s)26.6845.1020 %Zydis Lingualtabletten: Ondansetronum 8 mgSandoz
Pharmaceuticals AG		B / SL / SOG
L IPCI Ondansetron ODT Labatec 4 mg10 Tablet(s)22.6040.9510 %Melting tablets: Ondansetronum 4 mgLabatec Pharma SAB / SL / SGG
L IPCI Ondansetron ODT Labatec 8 mg6 Tablet(s)22.6140.9510 %Melting tablets: Ondansetronum 8 mgLabatec Pharma SAB / SL / SGG
L IPCICMOndansetron ODT Sandoz 4 mg1022.6040.9510 %Melting tablets: Ondansetronum 4 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCICMOndansetron ODT Sandoz 8 mg622.6140.9510 %Melting tablets: Ondansetronum 8 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ondansetron-Teva 4 oro10 Tablet(s)22.6040.9510 %Melting tablets: Ondansetronum 4 mgTeva Pharma AGB / SL / SGG
L IPCI Ondansetron-Teva 8 oro6 Tablet(s)22.6140.9510 %Melting tablets: Ondansetronum 8 mgTeva Pharma AGB / SL / SGG
L IP  Ondansetron Accord 8 mg/4 ml557.5579.0010 %Concentrate for infusion: Ondansetronum 8mg / 4mlAccord Healthcare AGB / SL / SGG
L IP  Ondansetron Fresenius
i.v. 8 mg/4 ml		5 1 ampoule(s) à 4 ml57.5579.0010 %Concentrate for infusion: Ondansetronum 8mg / 4mlFresenius Kabi
(Schweiz) AG		B / SL / SGG
L IP  Ondansetron Labatec,
4mg/2ml		5 1 ampoule(s) à 2 ml30.9050.0010 %Concentrate for infusion: Ondansetronum 4mg / 2mlLabatec Pharma SAB / SL / SGG
L IP  Ondansetron Labatec,
8mg/4ml		5 1 ampoule(s) à 4 ml57.5579.0010 %Concentrate for infusion: Ondansetronum 8mg / 4mlLabatec Pharma SAB / SL / SGG
L IP  Ondansetron-Teva 4mg/2ml5 x 2 ml30.8650.0010 %Concentrate for infusion: Ondansetronum 4mg / 2mlTeva Pharma AGB / SL / SGG
L IP  Ondansetron-Teva 8mg/4ml5 x 4 ml57.5579.0010 %Concentrate for infusion: Ondansetronum 8mg / 4mlTeva Pharma AGB / SL / SGG
L IPCI Ondansetron Labatec 4 mg10 Tablet(s)20.5638.8510 %Coated tablets: Ondansetronum 4 mgLabatec Pharma SAB / SL / SGG
L IPCI Ondansetron Labatec 8 mg6 Tablet(s)20.5638.8510 %Coated tablets: Ondansetronum 8 mgLabatec Pharma SAB / SL / SGG
L IPCICMOndansetron Sandoz 4 mg1020.5638.8510 %Coated tablets: Ondansetronum 4 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCICMOndansetron Sandoz 8 mg620.5638.8510 %Coated tablets: Ondansetronum 8 mgSandoz
Pharmaceuticals AG		B / SL / SGG
L IPCI Ondansetron-Teva, 4 mg10 Tablet(s)20.5638.8510 %Coated tablets: Ondansetronum 4 mgTeva Pharma AGB / SL / SGG
L IPCI Ondansetron-Teva, 8 mg6 Tablet(s)20.5638.8510 %Coated tablets: Ondansetronum 8 mgTeva Pharma AGB / SL / SGG
L IP CMOndansetron Sandoz 4 mg/2 ml10 x 2 ml61.7683.6010 %Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2mlSandoz
Pharmaceuticals AG		B / SL / SGG
L IP CMOndansetron Sandoz 8 mg/4 ml8 x 4 ml92.08116.5510 %Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4mlSandoz
Pharmaceuticals AG		B / SL / SGG
L IP  Ondansetron Accord 4 mg/2 ml530.8850.0010 %Konzentrat zur Herstellung einer Infusionslösung / Injektionslösung: Ondansetronum 4mg / 2mlAccord Healthcare AGB / SL / SGG
L IP  Ondansetron Fresenius
i.v. 4 mg/2 ml		5 1 ampoule(s) à 2 ml30.9150.0510 %Konzentrat zur Herstellung einer Injektions- /Infusionslösung: Ondansetronum 4mg / 2mlFresenius Kabi
(Schweiz) AG		B / SL / SGG
  IPCI Ondansetron Spirig HC 4 mg10k.A.Melting tablets: Ondansetronum 4 mgSpirig HealthCare AGBG
  IPCI Ondansetron Spirig HC 8 mg6k.A.Melting tablets: Ondansetronum 8 mgSpirig HealthCare AGBG
  IPCI Ondansetron Spirig HC 8 mg10k.A.Melting tablets: Ondansetronum 8 mgSpirig HealthCare AGBG
L IP CMOndansetron Sandoz 4 mg/2 ml5 x 2 ml30.8850.0010 %Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2mlSandoz
Pharmaceuticals AG		B / SL / SGG
L IP CMOndansetron Sandoz 8 mg/4 ml5 x 4 ml57.5579.0010 %Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4mlSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Ondansetron ODT Labatec 4 mg6 Tablet(s)k.A.Melting tablets: Ondansetronum 4 mgLabatec Pharma SABG
  IPCI Ondansetron ODT Labatec 8 mg10 Tablet(s)k.A.Melting tablets: Ondansetronum 8 mgLabatec Pharma SABG
  IPCI Ondansetron Labatec 8 mg10 Tablet(s)k.A.Coated tablets: Ondansetronum 8 mgLabatec Pharma SABG
Granisetron (A04AA02) 13 products WHO-DDD DrugBank.ca 
L IP  Kytril, Konzentrat zur
Herstellung einer
Infusionslösung 3 mg		5 ampoule(s)78.43101.0010 %Granisetronum 3mg / 3mlAtnahs Pharma
Switzerland AG		B / SL / SOG
L IP  Kytril, Konzentrat zur
Herstellung einer
Infusionslösung 1 mg		5 ampoule(s)34.0553.1510 %Granisetronum 1 mg/mlAtnahs Pharma
Switzerland AG		B / SL / SOG
L IP  Granisetron Fresenius
i.v. 1mg/1ml		5 ampoule(s)28.9447.9010 %Concentrate for infusion: Granisetronum 1 mg/mlFresenius Kabi
(Schweiz) AG		B / SL / SGG
L IP  Granisetron Fresenius
i.v. 3mg/3ml		5 ampoule(s)66.6788.9010 %Concentrate for infusion: Granisetronum 3mg / 3mlFresenius Kabi
(Schweiz) AG		B / SL / SGG
L IPCI Kytril 1 mg2 Tablet(s)11.5228.9510 %Coated tablets: Granisetronum 1 mgAtnahs Pharma
Switzerland AG		B / SLG
L IPCI Kytril 2 mgTablet(s)11.5228.9510 %Coated tablets: Granisetronum 2 mgAtnahs Pharma
Switzerland AG		B / SLG
  IPCI Kytril 1 mg10 Tablet(s)k.A.Coated tablets: Granisetronum 1 mgAtnahs Pharma
Switzerland AG		BG
  IPCI Kytril 2 mg5 Tablet(s)k.A.Coated tablets: Granisetronum 2 mgAtnahs Pharma
Switzerland AG		BG
  IP  Granisetron Labatec
1mg/ml		ampoule(s)k.A.Labatec Pharma SABG
  IP  Granisetron Labatec
1mg/ml		5 ampoule(s)k.A.Labatec Pharma SABG
  IP  Granisetron Labatec
3mg/3ml		ampoule(s)k.A.Labatec Pharma SABG
  IP  Granisetron Labatec
3mg/3ml		5 ampoule(s)k.A.Labatec Pharma SABG
     KytrilFertigspritze(n)k.A.Concentrate for infusion: 2 Active AgentsRoche Pharma
(Schweiz) AG		BG
Palonosetron (A04AA05) 5 products WHO-DDD DrugBank.ca 
LSIPIP  AloxiDurchstechflasche(n)44.8264.9010 %Injection solution: PalonosetronumMedius AGB / SL / SOG
L IP  Palonosetron Accord 0.25
mg/5 ml		 40.7760.7510 %Injection solution: PalonosetronumAccord Healthcare AGB / SL / SGG
L IP  Palonosetron-Teva 0.25
mg/5 ml		 40.7760.7510 %Injection solution: PalonosetronumTeva Pharma AGB / SL / SGG
L IP  Palonosetron Labatec 0.25 mg/ 5 ml 40.7760.7510 %solution injectable i.v.: PalonosetronumLabatec Pharma SAB / SL / SGG
L IPCI Aloxi 500 MikrogrammCapsule(s)62.4784.3510 %capsule molle: Palonosetronum 500 µgMedius AGB / SLG
Palonosetron, Combinations (A04AA55) 2 products WHO-DDD DrugBank.ca 
L IPCI Akynzeo IV 235 mg / 0.25 mg 77.72100.9510 %Concentrate for infusion: 2 Active AgentsMedius AGB / SLG
L IPCI Akynzeo 300 mg/0.5 mgCapsule(s)74.6397.6010 %Capsules: 2 Active AgentsMedius AGB / SLG
Other Antiemetics (A04AD) 2 products WHO-DDD  
   CIPhZintona10k.A.Capsules: Zingiberis Rhizomatis Pulvis (Zingiber Officinale Roscoe, Rhizoma) 250 mgMIT Gesundheit Swiss
GmbH		DG
   CIPhZintona20k.A.Capsules: Zingiberis Rhizomatis Pulvis (Zingiber Officinale Roscoe, Rhizoma) 250 mgMIT Gesundheit Swiss
GmbH		DG
Aprepitant (A04AD12) 3 products WHO-DDD DrugBank.ca 
LSIPIP  Ivemend 150 mgDurchstechflasche(n)58.2479.7510 %Lyophilisate: Fosaprepitantum 150 mgMSD Merck Sharp &
Dohme AG		B / SLG
LSIPIPCI Emend 125 mg3 Capsule(s)55.5376.8010 %Capsules: Aprepitantum 125 mgMSD Merck Sharp &
Dohme AG		B / SLG
 SIPIPCI Emend 80 mg - T2 Capsule(s)k.A.Capsules: Aprepitantum 80 mgMSD Merck Sharp &
Dohme AG		BG
Antiemetika, Homöopathika (A04AZ) 7 products WHO-DDD  
   CIHSimilasan Reisekrankheit15 gk.A.Globules: 4 Active AgentsSimilasan AGDG
   CIHCocculine30 Tablet(s)12.30k.A.Tablets: 4 Active AgentsBoiron SADG
   CIHSimilasan Reise-
Beschwerden N		60k.A.Tablets: 4 Active AgentsSimilasan AGDG
   CIHSimilasan Reisekrankheit60k.A.Tablets: 4 Active AgentsSimilasan AGDG
   CIHDr. Reckeweg R 52 Vomisan50 mlk.A.gouttes buvables: 8 Active AgentsLaboratoire Jacques
Reboh et fils SA		DG
   CIHSimilasan Reisekrankheit4.5 gk.A.Globules: 4 Active AgentsSimilasan AGDG
   CIHSimilasan Reise-
Beschwerden N		 k.A.Globules: 4 Active AgentsSimilasan AGG
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home